Upgrade to SI Premium - Free Trial

H.C. Wainwright Starts Agomab Therapeutics (AGMB) at Buy

June 22, 2026 6:07 AM
(Updated - June 22, 2026 6:11 AM EDT)

H.C. Wainwright analyst Patrick Trucchio initiates coverage on Agomab Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage